Co-Authors
This is a "connection" page, showing publications co-authored by Yutaro Yamaoka and Kei Miyakawa.
Connection Strength
1.303
-
Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera. J Mol Cell Biol. 2022 01 29; 13(12):918-920.
Score: 0.248
-
Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests. Cell Rep Med. 2021 06 15; 2(6):100311.
Score: 0.236
-
Whole Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 May Cause False-Positive Results in Serological Assays. Clin Infect Dis. 2021 04 08; 72(7):1291-1292.
Score: 0.235
-
Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles. J Mol Cell Biol. 2020 11 25; 12(12):987-990.
Score: 0.229
-
Development of highly sensitive and rapid antigen detection assay for diagnosis of COVID-19 utilizing optical waveguide immunosensor. J Mol Cell Biol. 2021 12 30; 13(10):763-766.
Score: 0.062
-
All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity. Viruses. 2021 08 23; 13(8).
Score: 0.060
-
Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19. PLoS One. 2021; 16(8):e0256022.
Score: 0.060
-
Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 Survivors. Front Microbiol. 2021; 12:661187.
Score: 0.059
-
Development of an Automated Chemiluminescence Assay System for Quantitative Measurement of Multiple Anti-SARS-CoV-2 Antibodies. Front Microbiol. 2020; 11:628281.
Score: 0.058
-
Potent antiviral effect of silver nanoparticles on SARS-CoV-2. Biochem Biophys Res Commun. 2020 11 26; 533(1):195-200.
Score: 0.056